Inside Innovation

Research device company NanoString Technologies has leased a 28,000-square-foot location in Bothell. The new facility will house instrument manufacturing, engineering, logistics, and support operations and

Kirkland, Washington has been ranked the third-best city in the U.S. to live in 2022, according to Money’s annual report. The rankings were based on

New findings from a Biogen and Eisai clinical trial reveal that the companies’ Alzheimer’s therapy, lecanemab, can slow cognitive decline. The news is promising for

Bothell-based biotech Seagen is partnering on a licensing deal with LAVA Therapeutics for its solid tumor technology. LAVA-1223, a preclinical medication that uses LAVA’s patented

Seattle-based biotech Alpine Immune Sciences is seeking $100 million in an underwritten public offering. The company of 130 employees has grown 65 percent over the

Seattle’s Institute for Systems Biology has been awarded $13 million by the National Cancer Institute. The money will be used to lead a collaborative cancer

The National Institute of Health has awarded the Allen Institute $173 million in funding for a variety of brain research initiatives. The nonprofit will get

The Seattle-based biotech company Tasso has received FDA clearance for its simple sample collection device, the Tasso+ lancet.The at-home self-collection device allows users to place

The Allen Institute, a nonprofit biotech research institution, is expanding into a new life sciences and technology campus near its South Lake Union headquarters. The

Shape Therapeutics, a Seattle-based biotech company, has been included in Fierce Biotech’s 2022 Fierce 15. This year’s list features a diverse range of companies with

Seattle-based biotech Good Therapeutics is being acquired by Swiss Pharmaceutical giant Roche for $250 million, plus further payments for specified milestones. Once the acquisition is

Seattle-based research institution Fred Hutch has received a $78 million gift from Stuart and Molly Sloan to launch a new institute dedicated to oncology research.